For your pharmacy to be eligible to become a service provider and participate in the Community Pharmacy in Health Care Homes Trial Program you must:
• Be approved to dispense pharmaceutical benefits as part of the Pharmaceutical Benefits Scheme (PBS) defined in Section 90 of the National Health Act 1953 (Cth) (Section 90 pharmacy).
• Abide by the 6CPA General Terms and Conditions available from www.6cpa.com.au
• Undertake to provide services under this Trial Program in accordance with these Trial Program Rules and relevant professional standards and Pharmacy Board of Australia guidelines.
• Be accredited by an approved Pharmacy Accreditation Program or be in the process of attaining Accreditation within six (6) months of lodging the application to become registered to participate in the Trial Program. The Commonwealth may waive the requirement to hold or be seeking accreditation in order to ensure patients can access the Trial Program.
• Undertake to obtain appropriate consent from the patient for the provision of services under the Trial Program prior to providing the services. A copy of a consent form is available online at www.6cpa.com.au
• Register and connect to the My Health Record system, and contribute up-to-date clinically relevant information to the patient’s My Health Record as appropriate, including the Medication Management Plan.
• Ensure that services delivered under the Trial Program are carried out by a Registered Pharmacist in an area of the community pharmacy approved premises that is physically separated from the retail trading floor so that the privacy and confidentiality of the patient is protected.
• The area must meet the following requirements:
- be appropriately furnished with facilities to allow the patient and the pharmacist to sit down together;
- be of sufficient size and appropriate layout to accommodate efficient workflow, including adequate room for the patient, their carer and the pharmacist as well as all the consumables, equipment and documentation required for the service;
- allow the patient and the pharmacist to talk at normal speaking volumes without being overheard by any other person (including pharmacy staff);
- be clearly sign posted as a private consultation area; Note: script in and out counters (including those with privacy screens) do not meet the consultation area requirements. When participating community pharmacies are providing services to patients in remote locations they may be provided via community pharmacy outreach into an alternative private space or via videoconference.
• When a Community Pharmacy is closed to members of the public, services under the Trial Program can be carried out in a public area of the pharmacy as long as the conversation between the Registered Pharmacist and the patient cannot be overheard by any other person (including pharmacy staff).
• Agree to accept the payment received under this Trial Program as full payment and provide any services under the Trial Program at no cost to patients; with the exception of Dose Administration Aids (DAA) (see section 4.4 for patient eligibility in Program Rules). Note: Service Providers may apply an additional consumer charge for a DAA service at their own discretion.